Ellis Lader, MD
Learn more about subscription options.
Register Now for a free account.
Lader E. Glargine did not reduce CV events more than standard care in patients with dysglycemia. Ann Intern Med. 2012;157:JC3–10. doi: 10.7326/0003-4819-157-6-201209180-02010
Download citation file:
Published: Ann Intern Med. 2012;157(6):JC3-10.
Cardiology, Coronary Risk Factors, Diabetes, Endocrine and Metabolism.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only